PL369552A1 - Pharmaceutical or/and nutrient or/and laboratory preparation for increasing, supporting the functioning of nerve cells and nervous system as well as application of pharmaceutical or/and nutrient or/and laboratory preparation in protection of the functions - Google Patents
Pharmaceutical or/and nutrient or/and laboratory preparation for increasing, supporting the functioning of nerve cells and nervous system as well as application of pharmaceutical or/and nutrient or/and laboratory preparation in protection of the functionsInfo
- Publication number
- PL369552A1 PL369552A1 PL369552A PL36955204A PL369552A1 PL 369552 A1 PL369552 A1 PL 369552A1 PL 369552 A PL369552 A PL 369552A PL 36955204 A PL36955204 A PL 36955204A PL 369552 A1 PL369552 A1 PL 369552A1
- Authority
- PL
- Poland
- Prior art keywords
- nutrient
- pharmaceutical
- laboratory preparation
- functioning
- functions
- Prior art date
Links
- 235000015097 nutrients Nutrition 0.000 title 2
- 210000000653 nervous system Anatomy 0.000 title 1
- 210000002569 neuron Anatomy 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
- A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/194—Carboxylic acids, e.g. valproic acid having two or more carboxyl groups, e.g. succinic, maleic or phthalic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Biomedical Technology (AREA)
- Veterinary Medicine (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Psychology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PL369552A PL369552A1 (en) | 2004-08-12 | 2004-08-12 | Pharmaceutical or/and nutrient or/and laboratory preparation for increasing, supporting the functioning of nerve cells and nervous system as well as application of pharmaceutical or/and nutrient or/and laboratory preparation in protection of the functions |
PCT/PL2005/000051 WO2006016828A2 (en) | 2004-08-12 | 2005-08-11 | Use of alpha ketoglutarate for treating alzheimer, parkinson |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PL369552A PL369552A1 (en) | 2004-08-12 | 2004-08-12 | Pharmaceutical or/and nutrient or/and laboratory preparation for increasing, supporting the functioning of nerve cells and nervous system as well as application of pharmaceutical or/and nutrient or/and laboratory preparation in protection of the functions |
Publications (1)
Publication Number | Publication Date |
---|---|
PL369552A1 true PL369552A1 (en) | 2006-02-20 |
Family
ID=35462217
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PL369552A PL369552A1 (en) | 2004-08-12 | 2004-08-12 | Pharmaceutical or/and nutrient or/and laboratory preparation for increasing, supporting the functioning of nerve cells and nervous system as well as application of pharmaceutical or/and nutrient or/and laboratory preparation in protection of the functions |
Country Status (2)
Country | Link |
---|---|
PL (1) | PL369552A1 (en) |
WO (1) | WO2006016828A2 (en) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2665466T3 (en) | 2010-02-18 | 2018-04-25 | Osiris Therapeutics, Inc. | Applications related to immunocompatible chorionic membrane products |
DK2897604T3 (en) * | 2012-09-19 | 2018-08-06 | Grespo Ab | COMPOSITIONS FOR IMPROVING BRAIN FUNCTION |
US20150328176A1 (en) * | 2013-01-25 | 2015-11-19 | Winning The Fight Inc. | Composition for treatment of neurodegenerative disease |
WO2019038655A1 (en) * | 2017-08-21 | 2019-02-28 | The Regents Of The University Of California | Compositions and methods for treating neurodegenerative diseases |
CN117530940A (en) * | 2023-10-11 | 2024-02-09 | 四川大学华西第二医院 | Application of alpha-ketoglutarate in preparation of medicines for promoting myelin repair and improving neuroinflammation |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE9402027D0 (en) * | 1994-06-10 | 1994-06-10 | Pharmacia Ab | Energy substrates |
WO1999021565A1 (en) * | 1997-10-24 | 1999-05-06 | Cornell Research Foundation, Inc. | Nutritional supplement for cerebral metabolic insufficiencies |
DE19755367C2 (en) * | 1997-12-12 | 2001-03-22 | Afting Ernst Guenter | Pharmaceutical composition containing D-galactose and its use |
US20050085498A1 (en) * | 1998-05-28 | 2005-04-21 | Byrd Edward A. | Oral formulation of lipid soluble thiamine, lipoic acid, creatine derivative, and L-arginine alpha-ketoglutarate |
US6093743A (en) * | 1998-06-23 | 2000-07-25 | Medinox Inc. | Therapeutic methods employing disulfide derivatives of dithiocarbamates and compositions useful therefor |
US20020193335A1 (en) * | 2001-03-02 | 2002-12-19 | Hesson David P. | Gene therapy for neurological tissues |
FR2822704B1 (en) * | 2001-03-29 | 2005-02-18 | Chiesi Sa | SALTS OF KETOACIDES AND GASTRORESISTANT AMINO ACIDS AND THEIR USE FOR THE PREPARATION OF MEDICAMENTS |
NZ530554A (en) * | 2004-01-13 | 2004-04-30 | A | Neuronutrients |
-
2004
- 2004-08-12 PL PL369552A patent/PL369552A1/en not_active Application Discontinuation
-
2005
- 2005-08-11 WO PCT/PL2005/000051 patent/WO2006016828A2/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
WO2006016828A8 (en) | 2007-07-19 |
WO2006016828A2 (en) | 2006-02-16 |
WO2006016828A3 (en) | 2006-06-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2008080134A3 (en) | 4-amin0-2- (hetero) arylamino-5- (hetero) arylthiazoles useful as axl inhibitors | |
CL2007002017A1 (en) | COMPOUNDS DERIVED FROM [4,5 '] - BIPIRIMIDINIL-6,4'-DIAMINE; PHARMACEUTICAL COMPOSITION; AND USE AS AN INHIBITOR OF THE ACTIVITY OF CINASA IN CANCER DE VEJIGA, CANCER CERVICAL AND MIELOMA MULTIPLE. | |
EP2476679A3 (en) | Substituted triazoles useful as AXL inhibitors | |
TWI320316B (en) | Methods for inhibiting hscd activity,pyridazine derivatives and use and pharmaceutical composition thereof | |
EP1844022A4 (en) | Quinazoline derivatives for inhibiting cancer cell growth and method for the preparation thereof | |
IL182876A0 (en) | Lactam compounds and their use as pharmaceuticals | |
WO2007022245A3 (en) | Patient compliance system and method to promote patient compliance | |
ZA200610576B (en) | Ablation apparatus and system to limit nerve condition | |
IL192009A0 (en) | Quinazoline derivatives, process for their preparation and their use as anti-cancer agents | |
ZA200608029B (en) | Nitrogenous fused-ring derivatives, medicinal compositions containing the derivatives, and use thereof as drugs | |
EP1963500A4 (en) | Compositions comprising oriented, immobilized macromolecules and methods for their preparation | |
ZA201000314B (en) | 2, 3-dihydrobenzo[1, 4] dioxin-2-ylmethyl derivatives as alpha2C antagonists for use in the treatment of peripheric and central nervous system diseases | |
IL185353A0 (en) | Azabicycloalkane derivatives , pharmaceutical compositions containing the same and methods for the preparation thereof | |
HK1207883A1 (en) | Cell culture method and utilization of the same | |
IL190219A0 (en) | Compounds which have activity at m1 receptor and their uses in medicine | |
IL179253A0 (en) | Pyrimidine derivatives and pharmaceutical compositions containing the same | |
IL190231A0 (en) | Phenyl-and pyridinyl-1,2,4-oxadiazolone derivatives processes for their preparation and their use as pharmaceuticals | |
HK1112916A1 (en) | 3-aminocarbazole compounds, pharmaceutical composition containing the same and method for the preparation thereof 3- | |
ME01400B (en) | Novel azabicyclic derivatives, preparation method thereof and pharmaceutical compositions containing same | |
ZA200700397B (en) | Novel benzamidine derivatives, process for the preparation thereof and pharmaceutical composition comprising the same | |
WO2006009765A3 (en) | Methods for the identification and use of compounds suitable for the treatment of drug resistant cancer cells | |
EP2035406A4 (en) | Novel substituted-1h-quinazoline-2,4-dione derivatives, preparation method thereof and pharmaceutical composition containing the same | |
PL369552A1 (en) | Pharmaceutical or/and nutrient or/and laboratory preparation for increasing, supporting the functioning of nerve cells and nervous system as well as application of pharmaceutical or/and nutrient or/and laboratory preparation in protection of the functions | |
WO2006133194A3 (en) | Methods for treating viral infection with oral or injectible drug solution | |
HK1124780A1 (en) | Amidine derivatives and their uses as medicine |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
REFS | Decisions on refusal to grant patents (taken after the publication of the particulars of the applications) |